Literature DB >> 15188513

Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma.

Shui Wang1, Yong-Bin Ding, Guo-Yu Chen, Jian-Guo Xia, Zhen-Yan Wu.   

Abstract

AIM: To investigate the relationship between methylation of Syk (spleen tyrosine kinase) gene in promoter region and oncogenesis, metastasis of gastric carcinoma. The relation between silencing of the Syk gene and methylation of Syk promoter region was also studied.
METHODS: By using methylation-specific PCR (MSP) technique, the methylation of Syk promoter region in specimens from 61 gastric cancer patients (tumor tissues and adjacent normal tissues) was detected. Meanwhile, RT-PCR was used to analyse syk expression exclusively.
RESULTS: The expression of the Syk gene was detected in all normal gastric tissues. Syk expression in gastric carcinoma was lower in 14 out of 61 gastric cancer samples than in adjacent normal tissues (chi(2)=72.3, P<0.05). No methylation of Syk promoter was found in adjacent normal tissues. hypermethylation of Syk gene in promoter was detected 21 cases in 61 gastric carcinoma patients. The rate of methylation of Syk promoter in gastric carcinoma was higher than that in adjacent normal tissues (chi(2)=25.1, P<0.05). In 31 patients with lymph node metastasis, 17 were found with Syk promoter methylation. A significant difference was noted between two groups (chi(2)=11.4,P<0.05).
CONCLUSION: Hypermethylation leads to silencing of the Syk gene in human gastric carcinoma. Methylation of Syk promoter is correlated to oncogenesis and metastasis of gastric carcinoma. Syk is considered to be a potential tumor suppressor and anti-metastasis gene in human gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188513      PMCID: PMC4572276          DOI: 10.3748/wjg.v10.i12.1815

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

Review 1.  A view to a kill: signals triggering cytotoxicity.

Authors:  Julie Y Djeu; Kun Jiang; Sheng Wei
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

2.  Activation of c-K-ras mutations in human gastrointestinal tumors.

Authors:  N Arber; I Shapira; J Ratan; B Stern; H Hibshoosh; M Moshkowitz; M Gammon; I Fabian; Z Halpern
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

3.  Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.

Authors:  Ganapati H Mahabeleshwar; Gopal C Kundu
Journal:  J Biol Chem       Date:  2002-12-10       Impact factor: 5.157

4.  Methylation of selected CpGs in the human O6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing.

Authors:  R P Danam; X C Qian; S R Howell; T P Brent
Journal:  Mol Carcinog       Date:  1999-02       Impact factor: 4.784

5.  The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.

Authors:  P J Coopman; M T Do; M Barth; E T Bowden; A J Hayes; E Basyuk; J K Blancato; P R Vezza; S W McLeskey; P H Mangeat; S C Mueller
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

6.  Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines.

Authors:  Li Li; Peter E Shaw
Journal:  J Biol Chem       Date:  2002-02-21       Impact factor: 5.157

7.  Activation of Syk tyrosine kinase is required for c-Cbl-mediated ubiquitination of Fcepsilon RI and Syk in RBL cells.

Authors:  Rossella Paolini; Rosa Molfetta; Laurie O Beitz; Juan Zhang; Andrew M Scharenberg; Mario Piccoli; Luigi Frati; Reuben Siraganian; Angela Santoni
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

8.  Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer.

Authors:  Tatsuya Toyama; Hirotaka Iwase; Hiroko Yamashita; Yasuo Hara; Yoko Omoto; Hiroshi Sugiura; Zhenhuan Zhang; Yoshitaka Fujii
Journal:  Cancer Lett       Date:  2003-01-10       Impact factor: 8.679

Review 9.  Structure-based design of novel anticancer agents.

Authors:  F M Uckun; E A Sudbeck; C Mao; S Ghosh; X P Liu; A O Vassilev; C S Navara; R K Narla
Journal:  Curr Cancer Drug Targets       Date:  2001-05       Impact factor: 3.428

Review 10.  Syk: a new player in the field of breast cancer.

Authors:  Z A Stewart; J A Pietenpol
Journal:  Breast Cancer Res       Date:  2000-11-02       Impact factor: 6.466

View more
  12 in total

1.  Nucleocytoplasmic trafficking of the Syk protein tyrosine kinase.

Authors:  Fei Zhou; Jianjie Hu; Haiyan Ma; Marietta L Harrison; Robert L Geahlen
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

2.  Differential expression of spleen tyrosine kinase Syk isoforms in tissues: Effects of the microbial flora.

Authors:  Florentina Duta; Marina Ulanova; Daniel Seidel; Lakshmi Puttagunta; Sorin Musat-Marcu; Kevin S Harrod; Alan D Schreiber; Ulrich Steinhoff; A Dean Befus
Journal:  Histochem Cell Biol       Date:  2006-05-18       Impact factor: 4.304

3.  Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis.

Authors:  So-Hyun Shin; Kwang Ho Lee; Baek-Hee Kim; Sun Lee; Hwan Seok Lee; Ja-June Jang; Gyeong Hoon Kang
Journal:  Lab Invest       Date:  2014-10-13       Impact factor: 5.662

4.  The role of Syk kinase in ultraviolet-mediated skin damage.

Authors:  E Papazoglou; Z Y Huang; C Sunkari; J Uitto
Journal:  Br J Dermatol       Date:  2011-05-30       Impact factor: 9.302

Review 5.  Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.

Authors:  Mariya O Krisenko; Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2014-11-04

6.  Epigenetic contributions to cancer metastasis.

Authors:  David I Rodenhiser
Journal:  Clin Exp Metastasis       Date:  2008-04-02       Impact factor: 5.150

7.  Hypermethylation and prognostic implication of Syk gene in human colorectal cancer.

Authors:  Zuli Yang; Lijun Huo; Hao Chen; Beibei Ni; Jun Xiang; Liang Kang; Lei Wang; Junsheng Peng; Yunfei Yuan; Jianping Wang
Journal:  Med Oncol       Date:  2013-04-23       Impact factor: 3.064

8.  Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion.

Authors:  Tracy Layton; Cristel Stalens; Felizza Gunderson; Steve Goodison; Steve Silletti
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

9.  Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells.

Authors:  Thomas Wossning; Sebastian Herzog; Fabian Köhler; Sonja Meixlsperger; Yogesh Kulathu; Gerhard Mittler; Akihiro Abe; Uta Fuchs; Arndt Borkhardt; Hassan Jumaa
Journal:  J Exp Med       Date:  2006-11-27       Impact factor: 14.307

10.  Prognostic value of spleen tyrosine kinase in human solid tumors.

Authors:  Beibei Ni; Shi Li; Yang Liu; Yuqian Huang; Zesong Li
Journal:  Onco Targets Ther       Date:  2018-06-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.